David Ross Parkinson
biomedicine
3Sbio
China
Biography
Dr. David Ross PARKINSON was appointed as our independent non-executive Director on May 23, 2015 with such appointment taking effect on June 1, 2015. He is responsible for participating in decision-making and advising on issues relating to our Company’s significant events and corporate governance. From 2007 to 2012, Dr. Parkinson served as president and chief executive officer at Nodality, Inc., a biotechnology company focused on personalized medicine. Before that, he was a vice president and head of the clinical oncology therapeutic area at Amgen Inc. (a company listed on the NASDAQ with symbol AMGN). Dr. Parkinson served as a director of the American Association for Cancer Research (AACR) from 2006 to 2009. He served on the National Cancer Policy Forum of the Institute of Medicine from 2005 to 2011. Dr. Parkinson has received multiple awards and honors, including the top innovator award from the Multiple Myeloma Research Foundation in 2012 and the Wiley Medal from the USFDA in 1997. He delivered the 12th Andrew H. Weinberg Memorial Lecture at the Harvard University School of Medicine in 2008. Dr. Parkinson obtained a Doctor of Medicine degree (M.D.) at the University of Toronto Faculty of Medicine in 1974.
Research Interest
Medicine
